Archive | Hot Mandates RSS feed for this section

Hot Investor Mandate: Venture Investment Firm Open to Investing Across All Life Scienc-Related Sectors, with Focus in South California & Southwestern USA

15 Nov

A life-sciences focused venture capital firm is currently making investments out of its third fund. The firm primarily makes equity investment into seed and early stage rounds ranging from $250,000 to $1 million initially and up to $2 million over the lifetime of the investment. The firm is focused on companies located in Southern California and the Southwestern United States although they are open to review companies from throughout the US. The firm could make as many as 3 new investments over the next 6-9 months.

The firm is looking for companies in sectors of Therapeutics, Diagnostics, Medical Devices, Life Science Tools and Healthcare IT. The firm is agnostic in terms of subsectors and indications within these areas and is also interested in orphan indications and wireless medical devices. The firm looks to invest in early-stage companies including pre-clinical stage companies with some supporting in-animal data, although it is not a requirement.

The firm is looking for privately held companies with experienced management teams. The firm looks to play an active role as an investor and generally looks to take a board or board observer seat following investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: New York Family Office Seeks Oncology & Diabetes-Related Technologies, with Strongest Interests in Devices and Diagnostics

8 Nov

A family office based in New York, NY looks to invest in medical devices and diagnostics, but will also consider therapeutics and digital health. The firm prefers companies that have some proof of concept data, with some animal studies complete, and will invest through to clinical-stage companies. The firm generally co-invests in a syndicate, and will invest between $100-500K, depending on the stage of development of the company. The firm is currently interested in investing in companies located in North America.

The firm is focused primarily on medical devices and diagnostics, but will consider therapeutics, if they are first in class, and digital health, with a focus on AI-related technologies. The firm has focused on technologies related to oncology, diabetes and kidney diseases, but will consider other indications as well.

The firm is interested in companies with strong management teams. As the firm will generally co-invest, board representation is not usually required after investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: Venture Capital Firm Actively Seeking New Therapeutics & Medical Device Investment Opportunities in the USA

8 Nov

A venture capital firm with multiple offices throughout the USA currently has approximately $350 million in total assets under management. The firm is making 2-3 new investments every month from its newest fund. The firm typically makes investments ranging from $0.25 million to $6 million over the life of the company. The firm prefers to invest early at the Seed, Series A and Series B stage. The firm will consider investing in any industry segment, but there must be at least one other venture capital firm making their first investment in the company in this round. The firm only invests in US-based companies.

The firm is currently looking for new investment opportunities in the life sciences space. The firm is very opportunistic in terms of sectors, subsectors and indications. The firm is currently active in therapeutics companies that develop nucleic acid drugs and small molecules to treat oncology and infectious diseases. The firm is also active in medical devices companies that develop active diagnostic and therapeutic radiation devices, implantable devices and surgical devices.

The firm seeks to invest in private companies based in US and only acts as a co-investor in financing rounds. The firm invests in companies that already have at least one other venture capital firm making their first investment. The best time to engage with the firm is when a company has a term sheet or expression of interest from another Venture Capital Firm.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

%d bloggers like this: